Washington, D.C. – Leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers called on Senate and House leaders to advance legislation that would reform and modernize the process for bringing innovative diagnostics and clinical laboratory tests to market. In a letter to the Chairmen and Ranking members of the Senate Committee on Health, Education, Labor & Pensions (HELP) and House Energy and Commerce Committee, more than 80 organizations urged Congress to prioritize meaningful diagnostic oversight reform in 2018, including for laboratory developed tests (LDTs) and in vitro diagnostics (IVDs).
You are here
WASHINGTON, D.C. - AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that focuses on the value diagnostics bring to patients' health and health care, while addressing the need for regulatory modernization of the innovative companies that develop and manufacture diagnostic tests, has elected Doug Bryant, president and CEO of Quidel Corporation, as its new Board chair.
GENEVA, SWITZERLAND – On January 18, the AMR Industry Alliance launched its first report that shows the commitment of the life sciences industry to tackle the public health threat of antimicrobial resistance (AMR).